Basic Information
NOVOLOG
0169-2101
Regulatory Information
0169-2101
BLA020986
C73585
February 28, 2023
USA
These highlights do not include all the information needed to use NOVOLOG safely and effectively. See full prescribing information for NOVOLOG.NOVOLOG (insulin aspart) injection, for subcutaneous or intravenous useInitial U.S. Approval: 2000
HUMAN PRESCRIPTION DRUG LABEL
33
Company Information
622920320
Active Ingredients
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
Quantity: 1.25 mg in 1 mL
Code: 94255I6E2T
Class Code: IACT
GLYCERIN
Quantity: 16 mg in 1 mL
Code: PDC6A3C0OX
Class Code: IACT
METACRESOL
Quantity: 1.72 mg in 1 mL
Code: GGO4Y809LO
Class Code: IACT
HYDROCHLORIC ACID
Code: QTT17582CB
Class Code: IACT
SODIUM HYDROXIDE
Code: 55X04QC32I
Class Code: IACT
SODIUM CHLORIDE
Quantity: 0.58 mg in 1 mL
Code: 451W47IQ8X
Class Code: IACT
PHENOL
Quantity: 1.5 mg in 1 mL
Code: 339NCG44TV
Class Code: IACT
ZINC
Quantity: 19.6 ug in 1 mL
Code: J41CSQ7QDS
Class Code: IACT
Active Moieties
INSULIN ASPART
Code: D933668QVX